Laurus Labs Ltd
NSE:LAURUSLABS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Laurus Labs Ltd
NSE:LAURUSLABS
|
IN |
|
Saia Inc
NASDAQ:SAIA
|
US |
|
A
|
Arch Capital Group Ltd
F:RSK
|
BM |
|
Empire State Realty Trust Inc
NYSE:ESRT
|
US |
|
Jbs NV
F:Z98
|
NL |
|
Elixirr International PLC
F:54K
|
UK |
|
Dali Foods Group Co Ltd
F:05M
|
CN |
|
IBI Group Inc
TSX:IBG
|
CA |
|
H
|
HSBC Holdings PLC
BMV:HBCN
|
UK |
|
Cango Inc
F:9C0A
|
CN |
|
C
|
Carlos Casado SA
BCBA:CADO
|
AR |
|
Global-E Online Ltd
NASDAQ:GLBE
|
IL |
|
Jungfraubahn Holding AG
OTC:JFBHF
|
CH |
|
U
|
United States Steel Corp
XMUN:USX1
|
US |
|
ANTA Sports Products Ltd
OTC:ANPDY
|
CN |
|
V
|
Vince Holding Corp
F:VNC1
|
US |
|
BTCS Inc
F:BIC
|
US |
|
Erste Group Bank AG
VSE:EBS
|
AT |
|
D
|
Diageo PLC
XETRA:GUI
|
UK |
|
C
|
Capital & Counties Properties PLC
F:C20
|
UK |
|
Outcrop Silver & Gold Corp
OTC:OCGSF
|
CA |
|
S
|
Standard Lithium Ltd
AMEX:SLI
|
CA |
Bankruptcy Probability
Laurus Labs Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Laurus Labs Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IN |
|
Laurus Labs Ltd
NSE:LAURUSLABS
|
998.7B INR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
613.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
316.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
186.7B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
260.1B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Laurus Labs Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Laurus Labs Ltd has total debt of 22.2B INR. This includes both short-term (14.9B INR) and long-term (7.2B INR) debt.
You can find a full breakdown on its Balance Sheet.
